ARCHIVES

Review Of NCI Intramural Program Offers Over 60 Recommendations For Change

This article is from The Cancer Letter archive.

Vol. 21 No. 27 | July 7, 1995

Download PDF Visit The Full Archive

Related Articles

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

Lederberg Appointment As Panel Chairman Confirmed; Bernard Fisher will Be Names To The Other Vacancy

November 30, 1979

AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows

August 28, 2009

NCI Bypass Budget Calls For $5.98 Billion

December 6, 2002

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market

January 24, 2003

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000